1,2,4-Thiadiazoles as promising multifunctional agents for treatment of neurodegenerative diseases
- 1 June 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Russian Chemical Bulletin
- Vol. 65 (6), 1586-1591
- https://doi.org/10.1007/s11172-016-1486-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Heteroarylnitrones as Drugs for Neurodegenerative Diseases: Synthesis, Neuroprotective Properties, and Free Radical Scavenger PropertiesJournal of Medicinal Chemistry, 2008
- Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant propertiesBioorganic & Medicinal Chemistry, 2008
- Advances in the synthesis and recent therapeutic applications of 1,2,4-thiadiazole heterocyclesBioorganic & Medicinal Chemistry, 2006
- Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s diseaseExpert Opinion on Investigational Drugs, 2005
- Targeting acetylcholinesterase and butyrylcholinesterase in dementiaInternational Journal of Neuropsychopharmacology, 2005
- Oxidative stress mechanisms and potential therapeutics in Alzheimer diseaseJournal of Neural Transmission, 2004
- Cholinesterase inhibitors: new roles and therapeutic alternativesPharmacological Research, 2004
- Oxidative stress in brain aging: Implications for therapeutics of neurodegenerative diseasesNeurobiology of Aging, 2002
- First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's DiseaseJournal of Medicinal Chemistry, 2002
- A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to ButyrylcholinesteraseCurrent Medical Research and Opinion, 2001